Communicable Disease Review

Vocabulary practice cards covering the incubation periods, communicability, complications, and vaccine specifics for common airborne communicable diseases.

Varicella (Chickenpox) Incubation Period

$$2\text{ weeks}$$

Varicella Communicable Period

$2\text{ days}$ before rash to $5\text{ days}$ after rash

Varicella Most Common (MC) Complication

Pneumonia

Varicella Vaccine Details

Live vaccine, OKA strain administered SC

VZIG

Varicella-Zoster Immunoglobulin; used for immunocompromised individuals

Measles Virus Characteristics

Paramyxo, ssRNA, Enveloped

Measles Incubation Period

$$2\text{ weeks}$$

Measles Communicable Period

$4\text{ days}$ before rash to $5\text{ days}$ after rash

Measles Most Common (MC) Complication

Otitis media

Measles Most Common Cause (MCC) of mortality

Pneumonia

SSPE (Subacute sclerosing Panencephalitis)

A delayed complication of measles leading to reduced IQ

Measles Vaccine Strain

Live attenuated, SC, Edmonston Zagreb (DW)

Rubella Incubation Period

$$2\text{ weeks}$$

Rubella Communicable Period

$7\text{ days}$ before rash to $7\text{ days}$ after rash

CRS (Congenital Rubella Syndrome) Triad

Cataract, SNHL (Sensorineural Hearing Loss), and PDA (Patent Ductus Arteriosus)

Rubella Vaccine Strain

RA 27/3 strain; contraindicated (CI) in pregnancy

Diphtheria Incubation Period

$$2-5\text{ days}$$

Diphtheria Case Management

Isolation until $2$ negative cultures, Macrolides for $14\text{ days}$, and Antitoxin

Diphtheria Contact Management (< 3 doses)

Complete full toxoid course

Diphtheria Contact Management (> 3 doses and > 5 years)

Administer DT dose (Booster)

COVID-19 Incubation Period

$$2-10\text{ days}$$

COVID-19 Communicable Period

$2\text{ days}$ before onset to $10\text{ days}$ after

COVID-19 Receptors

ACE-2 and TMPRSS-2 receptors located on Type 2 Pneumocytes